Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011860 (
type 2 diabetes
)
57,723
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Type 2 diabetes is a common complex disorder with environmental and genetic components. The aim of the present study was to investigate the association between the polymorphisms of
RAPGEF1
, TP53 and NRF1 and the risk of
type 2 diabetes
in the Chinese Han population. We genotyped rs11243444 (
RAPGEF1
), rs1042522 (TP53) and rs1882095 (NRF1) in a case-control study, including 273
type 2 diabetes
and 247 healthy controls. A significant association was found in a variant of TP53 (rs1042522, odd ratio (OR)=1.28, 95% confidence interval (CI)=1.00-1.64; P=0.046), whereas polymorphisms in
RAPGEF1
, NRF1 were not associated with the risk of
type 2 diabetes
. Furthermore, a potential gene-gene interaction showed the odds of being affected with
type 2 diabetes
was 2.54 times greater in subjects with the TP53 (rs1042522) and
RAPGEF1
(rs11243444) risk alleles than those without either (95% CI=1.34-4.81; P=0.004) and the NRF1 gene polymorphism reached significance when paired with TP53:(OR=3.87, 95% CI=1.87-8.40; P=0.0006). We demonstrated that the polymorphism in TP53 (rs1042522) was associated with
type 2 diabetes
, and that potential interaction of TP53 (rs1042522) and
RAPGEF1
(rs11243444), or NRF1 (rs1882095) increased the risk of
type 2 diabetes
.
...
PMID:Association between polymorphisms in RAPGEF1, TP53, NRF1 and type 2 diabetes in Chinese Han population. 2114 86